Loading viewer...
presentation
Format: PDF presentation
inhibrx-bio-investor-deck-august-2024 by Inhibrx.
Let us design a presentation that delivers.
brochure
INBRX-106 Hexavalent Anti-OX40 Agonist Inhibrx Solid Tumors
Cerevel Therapeutics Holdings
Raymond James Financial
investor_presentation
1 Pages
Inhibrx 2022 Investor Presentation - Clinical Pipeline Update
46 Pages
Inhibrx INBRX-109 Phase 1 Ewing Sarcoma Clinical Trial 2021
conference
Inhibrx INBX Investor Presentation September 2023
36 Pages
Synaptics
PCC Airfoils
Michelin
Bumrungrad Hospital